Skip to content
patentreply.ai
Office Action responsePricingSecurityDocs

US 12,715,900 · Application 17/793,601

US Patent 12,715,900 — assignment history and current owner

Preparation Method For Semaglutide

Who owns US Patent 12,715,900?

US12715900 ("Preparation Method For Semaglutide") — current assignee: SHENZHEN JYMED TECHNOLOGY CO., LTD.. Status: Active, estimated expiration December 7, 2042. 1 recorded USPTO assignment.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,715,900 is SHENZHEN JYMED TECHNOLOGY CO., LTD.. Based on the most recent ownership transfer record (recorded 2022-07-19).

Patent title
Preparation Method For Semaglutide
Application number
17/793,601
Apparent operating assignee
SHENZHEN JYMED TECHNOLOGY CO., LTD.
Patent status
Active, estimated expiration December 7, 2042
Recorded assignments
1

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Jul 18, 2022Jul 19, 2022Ownership TransferFU, YUQING; LI, WENJING; LI, XINYU; YAO, LIN; ZHANG, LIXIANGSHENZHEN JYMED TECHNOLOGY CO., LTD.60542/884

Scrolls sideways on narrow screens

Chain of title

In 2022, FU, YUQING; LI, WENJING (+3 more) assigned the patent to SHENZHEN JYMED TECHNOLOGY CO., LTD..

When does this patent expire?Look up another patent

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

The prosecution record for your AI

Application 17/793,601 · US 12,715,900

Ownership settled? Give your AI the file.

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,715,900, from the claims as filed to the last action, for Claude, ChatGPT, Cursor, or another supported AI workspace.

One new public application a month is free. The first compile takes a few minutes.

Connect PatentReplySee the evidence

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.

patentreply.ai
How it worksOffice Action responsePricingDocsConnectToolsSecurityPrivacyTermsContact

© 2026 patentreply.ai

PatentReply does not train on your matters. PatentReply is not a law firm and does not practice law; it requires attorney involvement where legal judgment belongs, and you remain the practitioner of record.